Contact Kinex Pharmaceuticals

About Us Team Pipeline News Contact Us Home
Kinex raises more than $3 million in equity financing

Kinex Co-Founder Appointed to NYBA Board

Kinex Awarded US Patent

Start of Clinical Trial for KX2-391

KX2-391 Enters Phase 1 Clinical Trials for Oncology

More headlines ...

Kinex News


Back to headlines

August 20, 2004
Kinex Elects New Member to Board of Directors

Kinex Pharmaceuticals has announced today that Mr. Donald A. Hess has been elected to join its Board of Directors.

Hess, an MIT- educated, Buffalo, NY-based entrepreneur, co-founded Amherst Systems. Amherst Systems that developed electronic test systems and measurement equipment grew to over 300 employees from its inception in 1975 until its sale to Comptek Research in 1999. It is now part of Northrop Grumman and located on Wehrle Drive in Amherst, New York.

Johnson YN Lau, Executive Chairman of Kinex stated, "Don brings significant management experience and expertise to our board. We believe his experience will contribute to the future growth of Kinex as we move forward on both business and scientific fronts”.

Mr. Hess serves as Vice Chairman on the Board of Directors of the Hauptman-Woodward Medical Research Institute and is active in private equity investing through Amherst Tech Ventures LLC, the Western New York Venture Association and the Toronto Angel Group.

About Kinex Pharmaceuticals: Kinex Pharmaceuticals, is a product-oriented drug discovery company with a unique technology platform and extensive pharmaceutical expertise focusing on Next Generation anti-cancer drug discovery and development, against validated molecular targets.